MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
4.160
-0.090
-2.12%
After Hours: 4.270 +0.11 +2.64% 19:52 02/06 EST
OPEN
4.180
PREV CLOSE
4.250
HIGH
4.420
LOW
4.020
VOLUME
56.35K
TURNOVER
--
52 WEEK HIGH
46.60
52 WEEK LOW
3.356
MARKET CAP
5.45M
P/E (TTM)
-0.0032
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite Reports Successful Liver Transplant After Compassionate Use of Namodenoson
TipRanks · 1d ago
Can-Fite announces patient with liver cirrhosis treated with Namodenoson
TipRanks · 1d ago
Can-Fite BioPharma Announces Patient With Advanced Decompensated Liver Cirrhosis Underwent Liver Transplantation Following Treatment With Namodenoson
Benzinga · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 1d ago
Can-Fite BioPharma Reports Clinical Stabilization in Decompensated Liver Cirrhosis Patient Treated with Namodenoson
Reuters · 1d ago
Can-Fite BioPharma meldet erfolgreichen Einsatz von Namodenoson als Brücke zur Lebertransplantation bei dekompensierter Leberzirrhose
Reuters · 1d ago
Weekly Report: what happened at CANF last week (0126-0130)?
Weekly Report · 5d ago
Can-Fite BioPharma Calls March 3 Special Meeting to Address NYSE Audit Committee Non-Compliance
TipRanks · 01/27 21:47
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.